Free tirzepatide consultation
Talk to a real, licensed physician, not a chatbot. Your 15-minute visit covers your medical history, goals and dosing plan, and if tirzepatide is appropriate your prescription can be written the same day.
Care team available 24/7
Free consultationLicensed physicians in all 50 states
Tirzepatide is the active ingredient in Zepbound® and Mounjaro®, a once-weekly dual GIP and GLP-1 medication that reduces appetite from two directions. Meet a licensed physician in a 15-minute video visit. If tirzepatide is right for you, your prescription can be written the same day and delivered to your door in 24–48 hours.


How it works
100% online. Meet a doctor in 15 minutes. If prescribed, delivery in 24–48 hours.
Answer a short health questionnaire, then meet a licensed physician in a 15-minute telehealth visit. Same-day appointments are often available.
Your physician reviews your medical history during a secure video visit, decides whether treatment is appropriate and, if so, can issue your prescription the same day.
Your medication ships to your home within 24–48 hours of approval. Follow-ups, dose changes and refills are handled online.
Why Tirzepatide Medics
Talk to a real, licensed physician, not a chatbot. Your 15-minute visit covers your medical history, goals and dosing plan, and if tirzepatide is appropriate your prescription can be written the same day.
Once prescribed, tirzepatide ships straight to your door in secure, temperature-controlled packaging. No pharmacy trips and no waiting in line.
Tirzepatide is taken once a week. Your dose starts low and steps up gradually, which helps keep side effects manageable while you work toward your goal.
From $399/month with physician visits and medication included. No membership fees or contracts, and discounted 3- and 6-month packages.
A licensed physician evaluates your health history, weight-loss goals and eligibility. If tirzepatide fits, they create a personal treatment plan and support you at every dose step.
Book free consultationClinical results
The SURMOUNT-1 (NEJM, 2022) phase 3 trial enrolled 2,539 adults with obesity or overweight and followed them for 72 weeks. Average weight loss rose with dose: 15.0% at 5 mg, 19.5% at 10 mg and 20.9% at 15 mg, alongside a reduced-calorie diet and more physical activity.
In the head-to-head SURMOUNT-5 (2025) trial of 751 adults, tirzepatide produced 20.2% average weight loss over 72 weeks, compared with 13.7% for semaglutide.
Tirzepatide 15 mg · average weight loss
20.9%over 72 weeks (SURMOUNT-1)Tirzepatide vs semaglutide · head-to-head
20.2%vs 13.7% over 72 weeks (SURMOUNT-5)Individual results vary. Weight loss depends on dose, adherence, diet and activity. Your physician will set realistic goals at your free consultation.
Pricing
Self-pay pricing with no insurance needed. Every program includes visits with licensed physicians and your medication. No membership fees, and you can cancel anytime.
$399/month
Billed monthly
All-inclusive weight loss program with prescription GLP-1 medication (e.g. Mounjaro®, Zepbound™).
Packages are available at discounted rates. Brand-name medications are available at additional cost.
Get started$1,125/3 months
That’s $375/month
All-inclusive program with prescription GLP-1 medication (e.g. Mounjaro®, Zepbound™).
This offer cannot be combined with any other discount codes or promotions.
Get started$2,199/6 months
That’s $366.50/month
All-inclusive program with prescription GLP-1 medication (e.g. Mounjaro®, Zepbound™).
Free
$399/month
$799/3-month supply
$75/membership
Brand-name medications are available at additional cost. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality.
GLP-1 options
We’re here to help. Our team of experienced healthcare professionals can answer your questions, discuss your options, and help you find the best weight loss medication for your needs. Whether it’s Tirzepatide or another option, we’ll guide you through every step of the process.
Most popularCompounded Tirzepatide has the same active ingredient as Zepbound, with the added benefit of dosage customization. By targeting both GLP-1 and GIP receptors, this compounded medication enhances treatment plans for weight management and glycemic control, making it an efficient and economically advantageous choice for patients.

Ozempic is a well-known GLP-1 medication originally designed to treat type 2 diabetes. However, it’s also been proven effective for weight loss. Ozempic works by mimicking the hormone GLP-1, which regulates blood sugar levels and appetite. People using Ozempic often see 5-10% weight loss over time.

Wegovy is a higher-dose version of Semaglutide, specifically designed for weight loss. It’s one of the most powerful GLP-1 medications for reducing body fat. In clinical studies, people using Wegovy lost about 15% of their body weight. It’s administered via weekly injections and, combined with a healthy diet, can deliver impressive results.

Semaglutide is the active ingredient in both Ozempic and Wegovy. If you’re taking either of these medications, you’re already benefiting from Semaglutide’s powerful effects. This medication has been widely studied and is proven to help with both diabetes management and weight loss, making it a versatile option.

Mounjaro is another brand of Tirzepatide, specifically approved for treating type 2 diabetes, though it also offers significant weight loss benefits. Like Tirzepatide, it works on two hormonal pathways, making it incredibly effective at curbing hunger and promoting sustainable weight loss.

Zepbound is another option that contains Tirzepatide and is FDA-approved specifically for weight loss. This medication works similarly to Mounjaro, with the same dual-action approach that helps regulate blood sugar and reduce appetite. People using Zepbound in clinical trials have reported losing a significant percentage of their body weight.

If you’re looking for an oral option, Rybelsus might be a good fit. It’s the first GLP-1 medication available in pill form. While it’s primarily used for managing type 2 diabetes, Rybelsus has also shown potential for weight loss, making it a more convenient alternative for people who prefer not to take injections.

Contrave is a non-GLP-1 weight loss medication that combines two drugs—naltrexone and bupropion. These drugs work together to reduce cravings and control hunger. While it doesn’t have the same blood sugar benefits as Tirzepatide, Contrave is still a useful tool for people who struggle with emotional eating and appetite control.
Eligibility
Most adults who qualify have one or more of the following:
Tirzepatide must not be used by anyone with a personal or family history of MTC or MEN 2, during pregnancy, or by people under 18. It must be refrigerated. Your physician reviews your full history at the free consultation and decides whether treatment is appropriate. See the Zepbound® Prescribing Information.
Taking semaglutide, liraglutide or another GLP-1 and wondering whether a different medication would suit you better? Or moving from compounded tirzepatide to an FDA-approved brand? Your physician plans the switch, including timing and starting dose, and monitors how you respond.
Switch to tirzepatideStuck with slow refills, limited supply or little support from your current provider? At your free consultation, your physician reviews your current dose and recent labs and picks up where your last provider left off, with no gap in treatment and no starting over.
Transfer your careUnexpected side effects, a new dose, or wondering if tirzepatide is still right for you? A quick online consultation is all it takes to get clarity and a plan.
Patient stories
“After struggling with my weight for decades, Tirzepatide finally gave me the tool I needed to succeed. The telemedicine approach fit perfectly with my busy schedule in Birmingham, and I've lost 47 pounds in 7 months.”
“I’ve tried everything. Zepbound from Tirzepatide Medics is the only thing that’s worked. I’m down 35 pounds and feel amazing.”
“After struggling for years, Zepbound finally helped me break through my weight loss plateau. I’m down 35 pounds and feel better than ever!”
“As a busy mom in Edison, I needed something convenient and effective. Tirzepatide Medics delivered both. Down 27 pounds and still going!”
“Zepbound changed my life. I’ve tried everything, but this is the first treatment that worked. I’m down 40 pounds and feel amazing.”
“This program is a game-changer! I’ve dropped 15 pounds in just eight weeks with Tirzepatide. The ongoing support from my doctor keeps me motivated, and I love the convenience of telehealth.”
“I lost over 20% of my body weight in just a few months with Tirzepatide. The support and personalized care made all the difference.”
“Tirzepatide helped me control my appetite and boost my energy. My confidence has never been higher.”
“This treatment transformed my health and confidence—Tirzepatide in Indianapolis truly works.”
“Thanks to Tirzepatide and the expert care in Portland, I’ve seen steady weight loss and better control over my appetite. It’s a game-changer for anyone struggling with obesity or metabolic issues.”
Individual results vary.
Our physicians
Your prescription is reviewed and written by board-certified physicians and licensed clinicians, trained at respected U.S. medical schools and licensed in your state.
Board-certified OB/GYN with 40+ years in women's hormonal health and weight management.
Internal medicine physician with 30+ years in metabolic health, GLP-1 weight loss, and obesity care.
Board-certified physician guiding medical weight loss alongside the behavioral and appetite factors behind it.
Board-certified physician with 30+ years in men's health, hormone balance, and medical weight loss.
Board-certified family medicine physician with 20+ years in women's health, hormone balance, and weight management.
Board-certified internal medicine physician specializing in metabolic health and medical weight loss.
Medications

Zepbound (tirzepatide) is FDA-approved for chronic weight management in adults with obesity, or overweight with a weight-related condition, and for moderate-to-severe obstructive sleep apnea in adults with obesity. It acts on both GIP and GLP-1 receptors.
Prescribing information
Mounjaro (tirzepatide) uses the same dual GIP and GLP-1 mechanism. It is FDA-approved to improve blood sugar in adults with type 2 diabetes, not for weight loss. For chronic weight management, ask your physician about Zepbound.
Prescribing information| Medication | Mechanism | Dosing | Avg. weight loss | Route |
|---|---|---|---|---|
| Tirzepatide (Zepbound®, Mounjaro®) | Dual GIP and GLP-1 agonist | Once weekly | 20.9% at 15 mg | Injection |
| Semaglutide (Wegovy®) | GLP-1 agonist | Once weekly (injection) | 14.9% | Injection |
| Liraglutide (Saxenda®) | GLP-1 agonist | Once daily | 8.0% | Injection |
Each figure is the average weight loss from that medication’s own pivotal trial, so the trials differ in design and population. The only direct comparison is SURMOUNT-5, where tirzepatide and semaglutide were tested in the same 751 adults (20.2% vs 13.7%).
Dosing
The dosage of Tirzepatide will depend on your individual needs and how your body responds to the medication. Here’s a brief guide to typical dosages:
Most people start with a 2.5 mg dose of Tirzepatide once a week. This initial dose helps your body adjust to the medication and reduces the likelihood of side effects like nausea or vomiting.
The 2.5 mg dose is typically used for the first few weeks of treatment. Once your body has adjusted, your healthcare provider may increase the dose to enhance weight loss.
For many patients, the 10 mg dose provides optimal weight loss results. By this point in your treatment, you should be seeing noticeable changes in your weight and appetite.
If necessary, your healthcare provider may increase your dose to 12.5 mg to maximize the medication’s effectiveness. This higher dose is often recommended for patients who need more aggressive weight loss or have not seen sufficient results with the lower doses.
Always follow your healthcare provider’s instructions when taking Tirzepatide.
Do not change your dose without consulting your doctor.
Store the medication properly to ensure it remains effective.
Side effects
Like any medication, Tirzepatide can cause side effects in some people. While most side effects are mild and tend to resolve as your body adjusts to the medication, it’s important to be aware of them and know when to seek medical advice. Here’s a more detailed look at the common side effects and how they might affect you:
Nausea is one of the most common side effects experienced by people taking Tirzepatide. This is because the medication slows down how quickly food moves through your stomach, helping you feel full for longer. While this is beneficial for weight loss, it can also lead to feelings of nausea, especially in the early stages of treatment.
How to manage nausea:
Vomiting is less common than nausea but may occur, especially in the first few weeks of treatment. This can happen if your body is adjusting to the slower digestion caused by Tirzepatide. While vomiting can be unpleasant, it usually subsides as your body gets used to the medication.
How to manage vomiting:
Some people experience diarrhea when they first start taking Tirzepatide. This is because the medication can affect how your intestines process food and fluids. Diarrhea is usually mild and temporary, but in some cases, it can be more bothersome.
How to manage diarrhea:
Feeling tired or fatigued is another common side effect of Tirzepatide. This may be due to your body’s adjustment to lower blood sugar levels and reduced food intake, as well as the metabolic changes caused by the medication.
How to manage fatigue:
Headaches are another side effect that some people experience when taking Tirzepatide. These headaches may be related to changes in blood sugar levels or dehydration, especially if nausea and diarrhea have led to fluid loss.
How to manage headaches:
FAQ
Can’t find your answer? Our care team is available 24/7.
Tirzepatide is a once-weekly injectable medication that activates two hormone receptors, GIP and GLP-1. Together they reduce appetite, help you feel full sooner and improve how your body handles blood sugar. It is sold as Zepbound® for chronic weight management and Mounjaro® for type 2 diabetes.
Semaglutide (Wegovy®, Ozempic®) acts on GLP-1 receptors only, while tirzepatide acts on both GIP and GLP-1 receptors. In the head-to-head SURMOUNT-5 trial, adults taking tirzepatide lost 20.2% of their body weight on average over 72 weeks, compared with 13.7% on semaglutide.
Both contain tirzepatide. Zepbound® is FDA-approved for chronic weight management (and for obstructive sleep apnea in adults with obesity), while Mounjaro® is FDA-approved for type 2 diabetes. Your physician decides which, if either, is appropriate for you.
In the SURMOUNT-1 trial, adults lost an average of 15.0% of their body weight at 5 mg, 19.5% at 10 mg and 20.9% at 15 mg over 72 weeks, combined with diet and exercise. Individual results vary.
Book a free consultation, complete a short health questionnaire and meet a licensed physician in a 15-minute video visit. If tirzepatide is right for you, your prescription can be written the same day and your medication delivered in 24–48 hours.
Our tirzepatide program is $399/month, including physician visits and medication. The 3-month package is $1,125 ($375/month) and the 6-month package is $2,199 (as low as $366.50/month). Brand-name medications are available at additional cost.
Yes, under a physician’s guidance. Your physician reviews your current medication and dose, decides when to switch and what tirzepatide dose to start on, and monitors how you respond. Do not take both at the same time.
Many people notice less appetite within the first few weeks. Weight loss builds gradually as the dose increases; in SURMOUNT-1, weight continued to fall through 72 weeks of treatment.
Coverage for weight loss varies widely by plan. Our programs are self-pay, so you don’t need insurance. If your plan covers Zepbound® or Mounjaro®, your physician can tell you how to use it.
Treatment usually starts at 2.5 mg once weekly for 4 weeks. The dose can then increase in 2.5 mg steps at least 4 weeks apart (5, 7.5, 10, 12.5 mg) up to a maximum of 15 mg, depending on how you respond and tolerate it. Your physician sets your schedule.
Tirzepatide stands out because it targets two hormones, GLP-1 and GIP, while most other medications, like Ozempic or Wegovy, target only GLP-1. This dual action makes Tirzepatide more effective in reducing appetite and improving metabolism, which can result in greater weight loss compared to other medications.
Yes, Tirzepatide has been approved for weight loss even for people who do not have type 2 diabetes. In fact, the weight loss benefits of Tirzepatide have been so significant that it is now prescribed primarily for obesity management as well as diabetes.
You should always consult your healthcare provider before combining Tirzepatide with other medications. While Tirzepatide is generally safe, it can interact with other drugs, especially those that affect blood sugar levels or cause gastrointestinal symptoms.
The duration of Tirzepatide treatment depends on your weight loss goals and how your body responds to the medication. Many patients stay on it for 6-12 months or longer. Your healthcare provider will assess your progress and determine the right time to stop or adjust the treatment.
If you miss a dose, take it as soon as you remember. If your next scheduled dose is within 48 hours, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for the missed dose. Always follow your healthcare provider’s advice for missed doses.
Absolutely! Tirzepatide is most effective when combined with a balanced diet and regular exercise. In fact, the best weight loss results are seen when patients combine the medication with healthy lifestyle changes, as Tirzepatide helps control appetite and supports long-term weight management.
When you stop taking Tirzepatide, the appetite-suppressing effects will gradually wear off. Some patients may experience weight regain if they return to old eating habits. It’s important to maintain the healthy habits you’ve developed during your treatment to sustain weight loss after stopping the medication.
It’s advisable to limit alcohol consumption while taking Tirzepatide. Alcohol can affect your blood sugar levels and may increase the risk of side effects such as nausea or dizziness. Always consult your doctor about how alcohol might interact with your medication.
Insurance coverage for Tirzepatide can vary. Some plans cover it for treating diabetes, but not for weight loss. However, if your healthcare provider can demonstrate a medical need, some insurers may cover it for obesity management. Be sure to check with your insurance provider for specific details.
Tirzepatide may be safe for people with certain chronic conditions like high blood pressure or high cholesterol, but it’s important to discuss your full medical history with your doctor. If you have conditions like severe heart disease, pancreatitis, or a history of thyroid cancer, your healthcare provider may advise against using Tirzepatide.
Most patients start to notice weight loss within the first 4-6 weeks of taking Tirzepatide. However, more significant weight loss typically occurs over a period of several months. Maximum results, like a 15-20% reduction in body weight, are usually seen around the 6-12 month mark, depending on lifestyle changes and dosage.
If you have a history of an eating disorder, it’s crucial to discuss this with your healthcare provider before starting Tirzepatide. Since the medication affects appetite and hunger cues, it may need to be used cautiously in patients with past or current eating disorders to prevent potential complications.
Tirzepatide primarily promotes fat loss rather than muscle loss. However, like any weight loss regimen, it’s important to combine Tirzepatide with strength training and sufficient protein intake to preserve muscle mass during weight loss.
Many patients report an increase in energy levels as they lose weight with Tirzepatide. As your body sheds excess fat and your blood sugar levels stabilize, you may feel more energized and motivated to stay active. However, in the early stages, some patients might experience mild fatigue as their body adjusts to the medication.
Yes, Tirzepatide can be prescribed to people over the age of 65. However, the dosage and potential side effects may need to be closely monitored, as older adults may be more sensitive to certain medications. Your healthcare provider will determine the safest treatment plan based on your age and overall health.
The most common side effects of Tirzepatide include nausea, vomiting, diarrhea, and constipation. These side effects are usually mild and tend to decrease over time as your body gets used to the medication. If side effects persist or become severe, contact your healthcare provider for guidance.
Yes, Tirzepatide is effective at reducing visceral fat, which is the type of fat stored around the abdomen. Patients who take Tirzepatide often see a reduction in belly fat as they lose weight, which can also reduce the risk of obesity-related conditions such as heart disease and type 2 diabetes.
Yes, people with hypothyroidism can benefit from Tirzepatide for weight loss. However, it’s important to ensure that your thyroid condition is well-managed before starting the medication. Tirzepatide can help with weight loss even in individuals who struggle with hypothyroidism-related weight gain, but consult your doctor for personalized advice.
Yes, your doctor may recommend regular blood tests to monitor your blood sugar levels and other health markers while you’re taking Tirzepatide. This is especially important if you have type 2 diabetes or other health conditions that require ongoing monitoring.
Tirzepatide is typically used as a standalone treatment, but in some cases, your healthcare provider may recommend combining it with other weight loss strategies. However, it’s important not to combine Tirzepatide with other medications or treatments, such as diet pills, without consulting your doctor, as this could lead to unwanted side effects or interactions.
Now that you have a complete understanding of how Tirzepatide works and what to expect, are you ready to start your weight loss journey? Schedule your free consultation today and begin taking control of your health with Tirzepatide.
For further information, please refer to the official FDA and manufacturer sources:
Book a free consultation today. If your physician decides treatment is appropriate, you can get your prescription the same day and receive your medication at home within 24–48 hours.
Locations
Telehealth and prescribing rules differ by state. Pick yours to see how care works where you live.
Disclaimer: Individual results vary. Zepbound® (tirzepatide) is FDA-approved for chronic weight management. Mounjaro® (tirzepatide) is FDA-approved for type 2 diabetes and is not approved for weight loss. Weight-loss outcomes depend on diet, physical activity, starting weight, adherence and other factors.
Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Ozempic®, Wegovy®, Rybelsus® and Saxenda® are registered trademarks of Novo Nordisk A/S. Tirzepatide Medics is not affiliated with, endorsed or sponsored by these companies; mentions are for educational and comparative purposes.
Common side effects of tirzepatide include nausea, diarrhea, vomiting, constipation, decreased appetite, indigestion and stomach pain. Serious risks include pancreatitis, gallbladder problems, kidney problems, low blood sugar, serious allergic reactions and a possible risk of thyroid C-cell tumors. Do not use tirzepatide if you or a family member has had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are pregnant.
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. This content is for information only and is not medical advice. See our Medical Disclaimer and Medical Review Process.
Official sources